Novo Nordisk Weight Loss Injections Proven Effective for Diabetics and Non-Diabetics Alike

New study shows that weight loss injections developed by Novo Nordisk can also lead to significant weight loss. The injections were originally intended for diabetics but have been found to be effective for weight loss as well. The injections mimic a hormone called GLP1, which lowers blood sugar levels and works through various mechanisms in the body to promote weight loss.

The first injection, Saxenda, led to an 8% loss of body weight, followed by Ozempic and Vigobi, which were found to be even more effective for weight loss. The Vigobi injection, with a dosage of 2.4 milligrams, is taken gradually to reduce side effects. The injections will be available in pharmacies and prescribed by private doctors. The cost ranges from NIS 600 to NIS 1,250 depending on the dosage.

Treatment with weight loss injections can be continued as long as necessary and may be stopped at any time. Common side effects include bloating, nausea, vomiting, diarrhea, and changes in food preferences. While the injections can help with weight loss, a healthy lifestyle including proper nutrition and exercise is essential for long-term success. It’s important to consult with a healthcare professional before starting any new treatment or medication.

In conclusion, weight loss injections developed by Novo Nordisk have proven to be an effective tool for those looking to lose weight quickly. However, it’s important to remember that a healthy lifestyle is crucial for long-term success and should always be complemented with proper nutrition and exercise.